---

CIO Insight: Drug Scientists Slow to Adopt Open Source

“A surge in open-source technology offers many businesses a
potent combination of power and low cost, but the pharmaceutical
industry remains well behind the curve.

“That was the message at a session on data visualization and
integration at a semiannual meeting of the nation’s chemists in
Washington last week…”

Complete
Story